Diabetes
Advances in treatment
There are currently more than 500 potential medicines being researched for the treatment of diabetes. Advancing knowledge has increased awareness of how diabetes, weight gain, and risk for heart disease are all related. In recent years, many have hailed the widespread availability of GLP-1 oral and injectable agonists (for example, Ozempic) as a critical advance in how the condition is managed. GLP-1 agonists trigger insulin release, reduce glucose production in the liver, and promote a feeling of fullness. Such a breakthrough wouldn’t have been possible without thousands of diabetes patients volunteering for clinical research studies!
You can get involved
More than 400 million people around the world are impacted by diabetes. There are many opportunities for people with diabetes along with healthy volunteers to contribute to clinical research and help further the development of treatment and prevention options. Want to stay informed about trials near your home. Register with us today!
RECRUITING TRIALS
Latest News
Metabolic dysfunction-associated steatohepatitis (MASH)
Speaking with your PCP about MASH
Engaging your primary doctor in a conversation about risk for MASH liver disease doesn't have to be scary
2024-06-25T12:15:00Z
Diabetes
The recent rise of walking as exercise
Grab your sneakers, grab a friend, or grab your dog and get moving!
2023-12-05T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Losing excess weight together with an active lifestyle helps with the management of MASH, but where to begin?
2023-09-05T18:30:00Z
References
-
Mayo Clinic: Diabetes - Symptoms and causes - Mayo Clinic
-
Healthline.com: Top Diabetes Treatment Advancements in 2023 (healthline.com)